Laman UtamaEVGN • NASDAQ
add
Evogene Ltd
Tutup sebelumnya
$1.28
Julat hari
$1.24 - $1.31
Julat tahun
$0.95 - $2.87
Permodalan pasaran
11.15J USD
Bilangan Purata
92.55K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Hasil | 884.00K | -3.28% |
Perbelanjaan pengendalian | 3.82J | — |
Pendapatan bersih | -4.46J | — |
Margin untung bersih | -504.75 | — |
Pendapatan bagi setiap syer | -0.50 | 52.83% |
EBITDA | -2.78J | — |
Kadar cukai berkesan | -0.02% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 11.69J | -44.08% |
Jumlah aset | 33.93J | -17.19% |
Jumlah liabiliti | 21.55J | 2.49% |
Jumlah ekuiti | 12.38J | — |
Syer tertunggak | 8.71J | — |
Harga kepada buku | -3.12 | — |
Pulangan pada aset | -22.50% | — |
Pulangan pada modal | -51.15% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -4.46J | — |
Tunai daripada operasi | -2.30J | — |
Tunai daripada pelaburan | -989.00K | — |
Tunai daripada pembiayaan | 4.15J | — |
Perubahan bersih dalam tunai | 834.00K | — |
Aliran tunai bebas | -12.18J | — |
Perihal
Evogene is a computational biology company based in Israel, specializing in predictive biology platforms that leverage artificial intelligence and machine learning for life-science product development. Evogene's platforms focus on designing novel microbes, small molecules, and genetic elements for use in pharmaceuticals, agriculture, and related industries. In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
CEO
Diasaskan
1999
Tapak web
Pekerja
117
